By Clive Flashman
Following on from my last blog (Persuading the Unpersuadables) I’d like to discuss influencing patients’ behaviour from a slightly different perspective.
It has proven incredibly difficult in the past to move patients up the engagement curve (from engaged, to empowered, to activated). This is because it generally requires a behaviour change on their part, and often on the part of the clinician too (a whole separate series of blogs!).
By Clive Flashman, Managing Director of Flashfuture Consulting
(First published in association with CSC)
The other day I met with a new startup company that has as its core purpose the improvement of the health of people with chronic and pre-chronic conditions via a cognitive behavioural platform. This is not the first of this kind of solution I have seen, I'm sure it won't be the last.
Invariably, they all seek to do the following:
By Clive Flashman
I’ve just returned from presenting at this very interesting event, and was delighted to be asked to chair the proceedings on the second day. Speakers came from all over the world (with a preponderance from the Netherlands and the UK), from a range of commercial, governmental and academic institutions.
Interestingly, the focus at this event was far less on technology, and more on user-centred design and behavioural change. This was very refreshing as these important aspects are often missed in the clamour around Bots, AI, Big Data, AR and VR.
Should doctors “check out” their patients on social media before seeing them?
By Clive Flashman, Managing Director of Flashfuture Consulting
(First published in association with CSC)
When we go to the doctor, we may or may not have a pre-existing relationship with them. Maybe they are a family GP, who has known us since we were a kid and is almost a part of the family. Perhaps they are a doctor we have been referred to but never met before. Both hopefully know something about us, but there’s a difference between 20 years of visits and records and a short referral letter.
By Clive Flashman, Managing Director of Flashfuture Consulting
(First published in association with CSC)
Who should be able to access your most personal details?
Just over two years ago, and with very little publicity given the significance of what it was doing, Google launched Google Genomics. Google Genomics is a cloud-based service, aimed at large hospitals and medical universities. It allows them to move DNA data into Google’s server farms, and provides an interface or API to support detailed analysis of that data using the same algorithmic-based technology they apply to web searches.
